Abeona Therapeutics (ABEO) Tops Q2 EPS by 7c

Abeona Therapeutics (NASDAQ: ABEO) reported Q2 EPS of ($0.26), $0.07 better than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Abeona Therapeutics (ABEO) click here.

You May Also Be Interested In

• Citi upgrades O-I Glass to Buy with $9 price target, opens 90-Day upside catalyst watch
• TD Cowen Starts Lakefront Biotherapeutics (LKFT) at Buy
• Bally's Corp (BALY) PT Lowered to $11 at Macquarie